Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Page Options
E-Mail This Search
Clinical Trial Questions?
Get Help:
1-800-4-CANCER
or
LiveHelp online chat
Quick Links
Help Using the NCI Clinical Trials Search Form
Educational Materials About Clinical Trials
About NCI's Cancer Clinical Trials Registry
Dictionary of Cancer Terms
NCI Drug Dictionary
View Content for:
Patients
Health Professionals
Display:
Title
Description with:
Locations
Eligibility
Full Trial Description
Custom
Results 1-8 of 8 for your search:
Drug:
porfimer sodium
Find trials that include:
Any drugs shown
Trial Status:
Active
Hide Search Criteria
Show Search Criteria
Help with Results
Select All on Page
Sort by:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Show
10
25
50
100
200
Results per Page
1.
Phase III Randomized Study of Biliary Stenting With Versus Without Photodynamic Therapy Using Porfimer Sodium in Patients With Unresectable Locally Advanced, Recurrent, or Metastatic Cholangiocarcinoma and Other Biliary Tract Tumors
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
CRUK-PHOTOSTENT-02
, EU-20740, EUDRACT-2005-001173-96, ISRCTN87712758, CTA-20363/0207/001-0001, NCT00513539
2.
Efficiency Evaluation of Photodynamic Therapy With Photofrin® on Unresectable Type III or IV Cholangiocarcinomas
Phase:
Phase III
Type:
Treatment
Status:
Approved-not yet active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
PHRC 2006-01
, NCT00540735
3.
S-1 and Photodynamic Therapy in Cholangiocarcinoma
Phase:
Phase III
Type:
Treatment
Status:
Active
Age:
18 to 90
Sponsor:
Other
Protocol IDs:
2009-0056
, NCT00869635
4.
Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer
Phase:
Phase II, Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
Other
Protocol IDs:
WBPDT-577-04
, NCT00322699
5.
Phase II Study of Intraoperative Pleural Photodynamic Therapy Using Porfimer Sodium (Photofrin®) in Patients With Primary Resectable Non-Small Cell Lung Cancer and Pleural Spread
Phase:
Phase II
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
UPCC-05503
, 709070, UPCC-709070, NCT00601848
6.
Endoscopic Therapy of Early Cancer in Barretts Esophagus
Phase:
Phase II
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI, Other
Protocol IDs:
1399-05
, CA111603-01A1, NCT00217087
7.
Phase I Pilot Study of Photodynamic Therapy Using Porfimer Sodium in Patients With Recurrent Oral Cavity or Laryngeal Dysplasia or Recurrent In Situ or Stage I Squamous Cell Carcinoma of the Oral Cavity or Larynx
Phase:
Phase I
Type:
Treatment
Status:
Active
Age:
18 and over
Sponsor:
NCI
Protocol IDs:
RPCI-RPC-01-08
, RPC 01-08, NCT00530088
8.
Study of Photodynamic Therapy Using Porfimer Sodium in Patients With Non-Small Cell Lung Cancer With Obstructive or Hemorrhagic Endobronchial Disease
Phase:
No phase specified
Type:
Biomarker/Laboratory analysis, Treatment
Status:
Active
Age:
Not specified
Sponsor:
NCI
Protocol IDs:
OSU-07115
, OSU 07115, OSU-2008C0055, NCT00754910
Select All on Page
Help with Results
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute